What You Should Know:
– RADLogics today announced that it has secured 510(k) clearance from the FDA for the company’s novel AI-Powered chest X-ray pneumothorax application, which identifies and prioritizes chest X-ray scans that appear to contain a pneumothorax, a collapsed lung, for urgent radiologist review.
– RADLogics’ FDA cleared CT and X-ray solutions – including this application – are available to hospitals and healthcare systems throughout the U.S. for patient triage and management. All of these applications are available immediately through the Nuance AI Marketplace for Diagnostic Imaging.
RADLogics, a healthcare company developing AI-Powered solutions that support image analysis to improve radiologists’ productivity while enhancing patient outcomes, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its novel AI-Powered chest X-ray pneumothorax application. The clearance paves the way for healthcare providers, hospital networks, and clinicians to have access to artificial intelligence (AI) software that is trained via pattern recognition to process chest X-rays and immediately flag scans with a suspected pneumothorax, a collapsed lung, for urgent radiologist review.